AI Research Lab Opens at Mount Sinai’s Cardiac Unit
The lab will use artificial intelligence to support decision-making and advance research in interventional cardiology.
New York City-based Mount Sinai Fuster Heart Hospital has established the Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab.
Annapoorna Kini, MD, director of the Cardiac Catheterization Lab at the Mount Sinai Hospital, was named director of the new research facility, according to a September 15 news release.
The lab will use artificial intelligence to support decision-making and advance research in interventional cardiology.
Researchers aim to integrate AI-powered technologies across procedural and educational applications through internal and external collaborations, with a focus on applying AI to stratify risk, plan cases, and optimize outcomes.
Earlier this year, The Icahn School of Medicine at Mount Sinai has introduced the Center for Artificial Intelligence (AI) in Children's Health, marking the first dedicated initiative in New York City.
It was established under The Mindich Child Health and Development Institute and is co-sponsored by Mount Sinai's Windreich Department of Artificial Intelligence and Human Health.
Benjamin S. Glicksberg, Ph.D., a specialist in digital health and clinical informatics, has been appointed to lead the effort. He previously held positions at Mount Sinai and within a genomics-based drug discovery startup and has experience in genetics, genomic sciences, and AI-driven healthcare innovations.
The Center seeks to overcome the challenge of complex regulatory standards in pediatrics. It will leverage AI technologies to enhance diagnostics, tailor treatments, and improve healthcare delivery for children and adolescents.
Stay tuned for more such updates on Digital Health News